In use product safety assessment report for capecitabine (Feb 2014).

Please note – the content of this resource has not been updated since the publication date. Some information may be out of date and links to other documents or websites may not work. 

A UKMi Product Safety assessment on  capecitabine which describes the in-use medication safety considerations resultant from the product’s presentation or other predefined characteristics.  Potential next steps and mitigation actions are suggested.

UKMi Product Safety assessments are produced using the validated UKMi product assessment tool which can be found below.

The UKMi product safety assessment group would appreciate your views on the usefulness of this assessment. The UKMI product safety assessment group would appreciate your views on the usefulness of the assessments produced. We have devised a short survey which we would appreciate you completing, it should take approximately 10 minutes to complete. Click here – https://www.surveymonkey.com/r/UKMiProductSafetyAssessments – to complete the survey.

CapecitabineHigh Risk SituationsMedicines SafetySystem Safety

Attachments